Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. S4 Cap. Share Price
  4. S4 Cap. Share Regulatory News
  5. Director Declaration

Pin to quick picksS4 Cap. Regulatory News (SFOR)

S4 Cap. Information

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
41.55    -1.75 (-4.04%)
Bid:
41.30
Ask:
42.00
Spread: 0.70 (1.695%)
Market Cap: £276.67m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Director Declaration

27 Mar 2017 12:18

RNS Number : 6302A
Derriston Capital PLC
27 March 2017
 

Derriston Capital plc

 

Director Declaration

 

Derriston Capital plc, which has been created to consider opportunities within the global medical technology industry, announces that Harry Hyman, non-executive Chairman, is a non-executive Director of BioPharma Credit plc, which began trading on the London Stock Exchange this morning.

 

For information please contact:

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

lifesciences@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNMMGZFMNVGNZM
123456789
Date   Source Headline
2nd Sep 20243:45 pmRNSTotal Voting Rights
14th Aug 20247:00 amRNSNotice of Interim Results
1st Aug 20249:31 amRNSTotal Voting Rights
1st Aug 20249:30 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSIssue of Shares
24th Jul 202411:23 amRNSDirector/PDMR Shareholding
2nd Jul 20243:30 pmRNSDirector/PDMR Shareholding
2nd Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:30 amRNSTotal Voting Rights
28th Jun 20247:00 amRNSIssue of Equity
14th Jun 20243:02 pmRNSDirector/PDMR Shareholding
14th Jun 20247:00 amRNSIssue of Shares
6th Jun 20243:51 pmRNSResult of AGM
6th Jun 202412:00 pmRNSAGM Statement
3rd Jun 20249:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSIssue of Shares
10th May 20247:00 amRNSFirst Quarter Trading Update
9th May 202410:01 amRNSNotice of AGM
9th May 20247:00 amRNSIssue of Shares
3rd May 20249:00 amRNSIssue of Shares
30th Apr 202411:25 amRNSNotice of Q1 Trading Update
29th Apr 20247:00 amRNSBoard Change
3rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSAudited 2023 preliminary results
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSNotice of Results
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSIssue of Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SGRE
SGRE.L
LSE
0.00%
HSD
Hansard
LSE
-1.39%
RCOI
Riverstone Cred
LSE
0.67%
VERX
Vanguardftsedxu
LSE
0.91%
LWDB
Law Debenture
LSE
-1.31%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%
GEX
Georgina Energy
LSE
1.69%
PREM
Premier African Minerals
LSE
-16.00%
PANR
Pantheon Resources plc
LSE
31.07%
ALRT
Defence Holdings
LSE
0.00%